Article Versions Notes

Brandas C, Ludovico A, Parodi A, Moran O, Millo E, Cichero E, Baroni D. NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis. Biomolecules. 2021; 11(10):1417. https://doi.org/10.3390/biom11101417

Brandas, Chiara, Alessandra Ludovico, Alice Parodi, Oscar Moran, Enrico Millo, Elena Cichero, and Debora Baroni. 2021. "NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis" Biomolecules 11, no. 10: 1417. https://doi.org/10.3390/biom11101417

Brandas, C., Ludovico, A., Parodi, A., Moran, O., Millo, E., Cichero, E., & Baroni, D. (2021). NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis. Biomolecules, 11(10), 1417. https://doi.org/10.3390/biom11101417